EnBio Holdings, Inc (6092.T) Comparison with companies in other sectors?

EnBio Holdings, Inc has a share price of 8.10M. You can analyze EnBio Holdings, Inc (6092.T) competitors across different market sectors through stock heatmaps.

What are 6092.T's NET and operating margins?

EnBio Holdings, Inc (6092.T) operating margin is around 0.08, and net profit margin is approximately 0.04 as of the latest reports.

In what way does 6092.T's earnings per share (EPS) trend reflect its financial momentum?

EnBio Holdings, Inc (6092.T) EPS is 55.93 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for EnBio Holdings, Inc is 12.05, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for EnBio Holdings, Inc?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for EnBio Holdings, Inc like P/E which is 12.04, P/B which is 0.60, and PEG which is -0.23. Compare them with sector averages to evaluate if the stock is priced fairly.

EnBio Holdings, Inc

6092.T•JPX

Industrials

Specialty Business Services

¥674.00

¥5.00(0.75%)

EnBio Holdings, Inc (6092.T) Fundamental Analysis: Financial Health, Valuation, and Key Ratios

Dive into Apple Inc.’s fundamentals including valuation ratios, profitability, efficiency metrics, and financial health. Use this data to assess long-term investment quality and compare it with sector benchmarks.

EPS (TTM)

$55.93

P/E Ratio

12.05

ROE

0.05%

Net Margin

0.04%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$5.46B

Shares OutstandingTotal number of shares issued

$8.10M

Book Value/ShareNet worth per share

$1141.74

Revenue/ShareAnnual revenue per share

$1319.55

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$55.93

Net MarginNet income as percentage of revenue

4.24%

Operating MarginOperating income as percentage of revenue

7.94%

ROEReturn on shareholders' equity

5.010%

ROAReturn on total assets

2.14%

ROCEReturn on capital employed

5.17%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$407.32

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

$9.00

Dividend YieldAnnual dividend as percentage of stock price

1.34%

Financial Ratios Analysis data is not available for 6092.TFinancial Ratios Analysis details for 6092.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for 6092.TSector Benchmarking details for 6092.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for EnBio Holdings, Inc Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of EnBio Holdings, Inc. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account EnBio Holdings, Inc's unique business strengths and challenges.

Key Financial Metrics for EnBio Holdings, Inc

For EnBio Holdings, Inc, essential financial indicators include EPS 55.93, PE 12.05, and ROE 0.05. These key ratios reveal insights into EnBio Holdings, Inc's profitability, valuation, and operational health. Understanding these metrics enables you to compare EnBio Holdings, Inc with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of EnBio Holdings, Inc

Metrics like Net Margin 4.24% and ROA 2.14% shed light on how well EnBio Holdings, Inc is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether EnBio Holdings, Inc can sustain its operations and continue growing in the future.

Valuation and Market Position of EnBio Holdings, Inc

Using ratios such as P/B Ratio 0.60 and PEG Ratio -0.23, investors can assess whether EnBio Holdings, Inc is appropriately valued based on its financials and growth potential. These figures, combined with EnBio Holdings, Inc's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for EnBio Holdings, Inc

Financial health indicators, such as Debt/Equity Ratio 1.10 and Cash Flow -, provide a snapshot of EnBio Holdings, Inc's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like EnBio Holdings, Inc, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for EnBio Holdings, Inc

Investing in EnBio Holdings, Inc based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at EnBio Holdings, Inc focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;